AmeriBen / IEC Group Chooses Elsevier's MEDai

                AmeriBen / IEC Group Chooses Elsevier's MEDai

  PR Newswire

  ORLANDO, Florida, October 15, 2012

ORLANDO, Florida, October 15, 2012 /PRNewswire/ --

Risk Navigator Clinical ^® to provide AmeriBen with population management 
and analytics solution

Elsevier's MEDai , which empowers payers and providers to transform care
delivery and streamline operations through actionable analytics, today
announced a new licensing agreement with AmeriBen/IEC Group, a full-service
TPA (third-party administrator) and the largest group in the Northwest
possessing both human resource consulting and benefit administration services,
for MEDai's Risk Navigator Clinical® software. MEDai's Risk Navigator
Clinical will assist AmeriBen, which manages more than 150,000 lives, in its
population management. 

MEDai will provide AmeriBen with Risk Navigator Clinical , a robust solution
to analyze and understand their care populations, and execute on strategies to
improve the quality of care, reduce costs and waste, and ultimately impact
health for their members.

"Risk Navigator Clinical will help AmeriBen as a TPA to promote clinical
integration and care coordination in the various employee groups we serve,"
said Ben Wright, Chief Financial Officer and VP of Strategic Initiatives,
AmeriBen. "We are very excited to turn membership data into actionable
information from which we will be able to provide improved quality, better
outcomes in delivered care and reduced costs through analytical modeling to
our clients."

Risk Navigator Clinical leverages predictive analytics to transform raw data
into intelligent insight that payers can use to allocate resources efficiently
and intervene before adverse, costly outcomes occur. Through an easy-to-use
web interface, Risk Navigator's results outline areas that provide the
greatest potential for intervention and management, allowing stakeholders to
improve operations and set competitive premium rates.

"We are pleased to integrate Risk Navigator Clinical into AmeriBen to help it
manage its clients' populations, cut costs and improve overall health though
analytic modeling," said Thomas Zajac, President of Elsevier's MEDai. "Both
AmeriBen/IEC Group and MEDai believe that this relationship translates into a
powerful new value proposition for the many members overseen by AmeriBen."

For more information, please visit or call

About AmeriBen

AmeriBen is based in Meridian, Idaho, with additional offices in Salt Lake
City, Phoenix, Denver, and Portland. AmeriBen currently administers benefit
plans for over 85 employers and universities numbering 250,000 participant and
student lives. AmeriBen's focus on providing access to best in class networks,
organic growth and controlling medical trend has provided opportunities for
double-digit growth annually. For more information about AmeriBen visit .

About Elsevier's MEDai

Elsevier's MEDai, Inc., is a premier provider of advanced analytic solutions
and innovative transformation and advisory services for payers, providers,
ACOs and other healthcare entities. Utilizing our proprietary predictive
analytics and clinical technologies, we transform the data stream in
healthcare environments to improve care quality, reduce costs, and manage
population health. We empower our customers to assess and stratify patients
and populations, predict risk, identify cost drivers, forecast future health
costs, and drive decisions that improve outcomes. For more information on
MEDai, visit .

About Elsevier

Elsevier is a world-leading provider of scientific, technical and medical
information products and services. The company works in partnership with the
global science and health communities to publish more than 2,000 journals,
including The Lancet and Cell , and close to 20,000 book titles, including
major reference works from Mosby and Saunders. Elsevier's online solutions
include ScienceDirect , Scopus , Reaxys , ClinicalKey and Mosby's Nursing
Suite , which enhance the productivity of science and health professionals,
and the SciVal suite and MEDai's Pinpoint Review , which help research and
health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier employs 7,000 people
worldwide. The company is part of Reed Elsevier Group PLC , a world-leading
publisher and information provider, which is jointly owned by Reed Elsevier
PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL
(London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media contact Christopher Capot Director, Corporate Relations Elsevier